Group 1: Michael Burry's Investment Actions - Michael Burry sold off his entire investment portfolio in Q1, except for Estee Lauder, in which he doubled his position [2] - He bought put options on Nvidia and several Chinese ADRs, indicating a bearish outlook on these stocks [3] - Burry's actions suggest a strategic pivot, betting against the U.S. and Chinese markets while maintaining confidence in Estee Lauder [4] Group 2: Estee Lauder's Business Overview - Estee Lauder is a global beauty conglomerate with a portfolio of luxury brands, including Clinique, MAC, and La Mer [5] - The company has faced challenges due to its exposure to China and the duty-free shopping market, with sales in China recovering slowly post-COVID [6][7] - Increased competition from newer prestige beauty brands has also impacted Estee Lauder's market position in the U.S. [9] Group 3: Financial Performance and Strategy - Estee Lauder's sales declined by 10% and adjusted operating income fell by 27% last quarter, with retail travel revenue dropping 28% [14] - The company is implementing a profit recovery and growth plan, which includes cost reductions and layoffs to restore sales growth and improve margins [13] - Despite current challenges, if the company can regain lost earnings, there could be significant upside potential for its stock [15][16]

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against The Estee Lauder Companies Inc. regarding alleged breaches of fiduciary duties by its board of directors following a class action complaint filed on December 7, 2023 [1] Group 1: Allegations and Market Impact - The complaint alleges that Estee Lauder misled investors with unrealistic and materially false statements about market demand for its products and inventory levels [2] - These misleading statements concealed the company's market weaknesses until May 3, 2023, when Estee Lauder announced weaker-than-expected sales and profit, leading to a third consecutive cut in its fiscal year outlook [2] - Following this announcement, Estee Lauder's stock price fell from $245.22 per share on May 2, 2023, to $202.70 per share on May 3, 2023, reflecting a significant decline [2]

Core Viewpoint - The Clorox Company has elected Gina Boswell to its board of directors, effective May 19, 2025, enhancing its leadership with her extensive experience in the consumer goods sector [1][2][3]. Group 1: Board Appointment - Gina Boswell, 62, is the CEO of Bath & Body Works and has held senior roles at Unilever, Avon, Ford, and Estée Lauder, bringing a wealth of operational and leadership experience [2]. - Boswell's background in retail, marketing, brand building, business development, operations, and innovation will provide valuable insights into Clorox's business strategy and growth [2][3]. - With Boswell's appointment, the total number of Clorox board members will increase to 12 [3]. Group 2: Company Overview - The Clorox Company, headquartered in Oakland, California, has been a leader in integrating ESG into its business reporting since 1913 [4]. - Clorox was ranked No. 1 on Barron's 100 Most Sustainable Companies list for the third consecutive year in 2025 [4].

Core Insights - The Estee Lauder Companies Inc. reported third-quarter fiscal 2025 results with both net sales and earnings declining year over year, primarily due to weak consumer sentiment and reduced conversion rates in China [1][2] Financial Performance - Adjusted earnings were 65 cents per share, surpassing the Zacks Consensus Estimate of 29 cents, but down 33% from 97 cents in the prior year [2] - Quarterly net sales reached $3,550 million, exceeding the Zacks Consensus Estimate of $3,507.2 million, but reflecting a 10% decline year over year [2] - Organic net sales decreased by 9% to $3,605 million [2] Category-Wise Revenue Results - Skin Care sales fell 12% year over year to $1,807 million, impacted by weak consumer sentiment and lower conversion rates among Chinese shoppers [3] - Makeup revenues declined 9% to $1,035 million, primarily due to weaker sales from key brands like M·A·C and Estée Lauder [4] - Fragrance revenues decreased 3% to $557 million, largely due to lower performance from Clinique and Estee Lauder [4] - Hair Care sales totaled $126 million, down 12% year over year, mainly due to Aveda's weaker performance [5] Regional Revenue Results - Sales in the Americas fell 6% year over year to $1,052 million [6] - Revenues in the EMEA region declined 18% to $1,358 million [6] - Asia-Pacific region sales tumbled 3% to $1,140 million [6] Margin Analysis - Adjusted gross margin improved by 310 basis points to 75%, driven by the Profit Recovery and Growth Plan (PRGP) [7] - Adjusted operating margin contracted by 270 basis points to 11.4%, due to increased investments and sales volume deleverage [8] Financial Health - The company exited the quarter with cash and cash equivalents of $2,631 million, long-term debt of $7,298 million, and total equity of $4,345 million [9] - Net cash flow from operating activities for the nine months ended March 31, 2025, was $671 million, with capital expenditures of $395 million [10] Restructuring and Future Outlook - The PRGP aims to transform the operating model, with expected restructuring charges between $1.2 billion and $1.6 billion before taxes [12][13] - The company anticipates a decline in reported net sales of 8-9% for fiscal 2025, with adjusted organic net sales expected to fall by the same percentage [14] - Adjusted EPS is projected to slump by 40-50%, ranging from $1.30 to $1.55 for fiscal 2025 [15]

Sales Performance - Skin care net sales decreased by 12% to $1,807 million for the three months ended March 31, 2025, compared to $2,060 million in the same period of 2024[185]. - Makeup net sales decreased by 9% to $1,035 million for the three months ended March 31, 2025, compared to $1,136 million in the same period of 2024[185]. - Fragrance net sales decreased by 3% to $557 million for the three months ended March 31, 2025, compared to $575 million in the same period of 2024[185]. - Hair care net sales decreased by 12% to $126 million for the three months ended March 31, 2025, compared to $143 million in the same period of 2024[185]. - Net sales decreased by 10% to $3,550 million for the three months ended March 31, 2025, compared to $3,940 million in the prior year[223]. - The Americas region net sales were $1,052 million for the three months ended March 31, 2025, down from $1,117 million in the same period of 2024[185]. - Europe, the Middle East & Africa region net sales decreased to $1,358 million for the three months ended March 31, 2025, compared to $1,647 million in the same period of 2024[185]. - Asia/Pacific region net sales decreased to $1,140 million for the three months ended March 31, 2025, compared to $1,176 million in the same period of 2024[185]. - Net sales in The Americas decreased by 6%, primarily due to lower sales in North America and ongoing retail softness[197]. - Net sales in Europe, the Middle East & Africa decreased by 18%, driven by lower sales in the Asia travel retail business and strategic decisions to reduce exposure to reseller activity[197]. - Net sales in Asia/Pacific decreased by 3%, with declines in Korea, Hong Kong SAR, Singapore, Taiwan, and Australia, partially offset by growth in mainland China and Japan[197]. Operating Income and Expenses - Operating income decreased to $306 million for the three months ended March 31, 2025, compared to $531 million in the same period of 2024[185]. - Total operating expenses increased to 66.3% of net sales for the three months ended March 31, 2025, compared to 58.4% in the same period of 2024[187]. - Operating income decreased by 42% for the three months ended March 31, 2025, with an operating margin of 8.6%, down from 13.5% in the prior-year period[276]. - The unfavorable change in operating expense margin for the three months ended March 31, 2025 was influenced by higher advertising and merchandising expenses to support sales[274]. - Charges associated with restructuring and other activities for the three months ended March 31, 2025 amounted to $97 million, impacting overall operating income[277]. Earnings and Profitability - Net earnings attributable to The Estée Lauder Companies Inc. were 4.5% of net sales for the three months ended March 31, 2025, down from 8.4% in the same period of 2024[187]. - Net earnings attributable to The Estée Lauder Companies Inc. for the three months ended March 31, 2025, were $159 million, a decrease of 52% from $330 million in the prior year[301]. - Operating income as reported for the nine months ended March 31, 2025, was a loss of $395 million, compared to a profit of $1,203 million in the prior year, representing a decline of over 100%[309]. - Diluted net earnings per common share for the nine months ended March 31, 2025, were $(1.63), a decrease of over 100% from $1.87 in the prior year[309]. - The company reported a decrease in operating income as adjusted to $1,009 million for the nine months ended March 31, 2025, down 19% from $1,239 million in the prior year[309]. Restructuring and Future Plans - The company expects restructuring charges from the Profit Recovery and Growth Plan (PRGP) to total between $1,200 million and $1,600 million, before taxes[213]. - The PRGP aims to yield annual gross benefits of between $800 million and $1,000 million, before taxes, to support sales growth and improve profitability[214]. - The restructuring program is expected to result in a net reduction of approximately 5,800 to 7,000 positions globally, representing about 9-11% of total positions[212]. - The company is focusing on disciplined advertising and promotional expense management to mitigate declines in operating income across various segments[282][285]. - Future strategies may include targeted expansions and new product launches to enhance market presence and drive sales growth[285]. Cash Flow and Debt - As of March 31, 2025, the company had cash and cash equivalents of $2,631 million, down from $3,395 million at June 30, 2024[320]. - Total debt as a percentage of total capitalization increased to 63% at March 31, 2025, compared to 59% at June 30, 2024[329]. - Net cash flows provided by operating activities for the nine months ended March 31, 2025, were $671 million, a decrease from $1,471 million in the same period of 2024[331]. - The company’s outstanding borrowings totaled $7,301 million as of March 31, 2025, with long-term debt accounting for $7,298 million and current debt at $3 million[327]. Market Risks and Challenges - The company acknowledges potential risks affecting future performance, including increased competition in the skin care, makeup, fragrance, and hair care sectors[349]. - Future operating results may depend on the successful development, production, and marketing of new products[349]. - The company faces challenges from retail industry consolidations and potential bankruptcies, which could decrease the number of stores selling its products[349]. - Changes in consumer preferences regarding value perception and shopping habits may impact sales[349]. - The company is exposed to foreign currency fluctuations that could affect operational results and asset values[349]. - Global or local conditions, including economic policies and supply chain challenges, may influence consumer purchasing behavior[349]. - Shipment delays and increased production costs could arise from operational disruptions at manufacturing or distribution facilities[349].

Core Insights - Estee Lauder reported $3.55 billion in revenue for the quarter ended March 2025, a year-over-year decline of 9.9% with an EPS of $0.65 compared to $0.97 a year ago, exceeding the Zacks Consensus Estimate of $3.51 billion by 1.22% and delivering an EPS surprise of 124.14% against a consensus estimate of $0.29 [1] Revenue Performance - Net sales in the Americas were $1.05 billion, below the average estimate of $1.08 billion, reflecting a year-over-year decline of 5.8% [4] - Net sales in Asia/Pacific reached $1.14 billion, surpassing the average estimate of $1.02 billion, but still showing a year-over-year decrease of 3.1% [4] - Net sales in Europe, the Middle East & Africa totaled $1.36 billion, slightly below the average estimate of $1.40 billion, with a significant year-over-year decline of 17.6% [4] - Skin Care net sales were $1.81 billion, compared to the average estimate of $1.87 billion, marking a year-over-year decline of 12.3% [4] - Makeup net sales were $1.04 billion, below the average estimate of $1.07 billion, reflecting an 8.9% year-over-year decline [4] - Other net sales were $25 million, exceeding the average estimate of -$38.46 million, with a year-over-year change of -3.9% [4] - Hair Care net sales were $126 million, below the average estimate of $134.79 million, representing an 11.9% year-over-year decline [4] - Fragrance net sales were $557 million, slightly below the average estimate of $574.19 million, with a year-over-year decline of 3.1% [4] Operating Income Analysis - Hair Care reported an operating loss of $13 million, worse than the average estimate of -$7.17 million [4] - Skin Care achieved an operating income of $361 million, slightly above the average estimate of $354.08 million [4] - Other segments reported an operating income of $9 million, significantly better than the average estimate of -$220.82 million [4] - Makeup reported an operating income of $14 million, below the average estimate of $53.44 million [4] Stock Performance - Estee Lauder shares have returned -12.8% over the past month, compared to a -0.7% change in the Zacks S&P 500 composite, with a current Zacks Rank of 3 (Hold) indicating potential performance in line with the broader market [3]

Financial Data and Key Metrics Changes - Organic sales declined by 9%, with business excluding Travel Retail decreasing by 3% organically, showing sequential improvement from a 4% decline in the second quarter [6][30] - Diluted earnings per share decreased by 33% to $0.65, which was better than anticipated, indicating disciplined expense management [6][30] - Gross margin expanded over 300 basis points for the fourth consecutive quarter, driven by the Profit Recovery and Growth Plan (PRGP) [6][30] - Operating margin contracted by 270 basis points to 11.4%, influenced by increased consumer-facing spending [6][30] Business Line Data and Key Metrics Changes - Travel Retail experienced a significant decline of 28% organically, continuing to shrink as a percentage of the overall business [6][30] - Retail sales trends improved sequentially, with notable share gains in the U.S., China, and Japan, marking the first share gains in the U.S. in many years [7][9][31] - Clinique, The Ordinary, and Bumble and Bumble contributed to gains in the U.S., while La Mer and Estee Lauder drove growth in China [9][10] Market Data and Key Metrics Changes - The company gained market share in three of the last four quarters in China, with Clinique achieving eleven consecutive months of share gains in the U.S. [8][9] - Japan saw its fourth consecutive quarter of share gains, indicating strong brand performance in key markets [9][10] - Emerging markets in Southeast Asia also showed growth, with online organic sales growing in the mid-single digits [12][21] Company Strategy and Development Direction - The company is focused on its Beauty Reimagine strategic vision, aiming to transform its operating model to be leaner and more agile [5][30] - The PRGP is a key initiative, with plans to reduce over 2,600 net positions and streamline middle management by 20% [23][30] - The company is exploring expansion with new retailers and enhancing its online presence through platforms like Amazon and TikTok [10][12] Management's Comments on Operating Environment and Future Outlook - Management acknowledged elevated macroeconomic challenges but expressed confidence in returning to sustainable sales growth and achieving a solid double-digit adjusted operating margin in the coming years [5][30] - The outlook for fiscal 2025 anticipates continued headwinds in Travel Retail, with organic sales expected to decline between 9% to 8% [41][42] - Management is closely monitoring consumer sentiment, particularly in the U.S. and China, and is adjusting inventory levels accordingly [25][41] Other Important Information - The company generated $671 million in net cash flow from operating activities for the nine months, a decrease from $1.471 billion the previous year [35][36] - Capital expenditures were reduced by 44% to $395 million, reflecting a focus on optimizing capital expenditures [36][30] - The company is actively working on tariff mitigation strategies and regionalizing its supply chain to reduce exposure [37][39] Q&A Session Summary Question: Inventory alignment across categories and geographies - Management noted significant progress in reducing inventory levels, particularly in Travel Retail, and emphasized ongoing monitoring of retail inventory [46][48] Question: FY 2026 planning assumptions and market trends - Management expressed confidence in returning to positive growth in FY 2026, citing market share gains in key regions and ongoing improvements in retail sales [56][58] Question: Tariff sourcing and mitigation strategies - Management indicated plans to reduce the percentage of products sourced from China to below 10% by the end of the fiscal year, leveraging manufacturing capabilities in Japan and Europe [72][75] Question: Expectations for PRGP savings and reinvestment - Management confirmed they are on target for PRGP savings and are exploring further efficiencies, with a focus on outsourcing and procurement [84][87] Question: Sales growth and tariff impact on FY 2026 - Management clarified that the expectation for returning to growth in FY 2026 is a full-year comment, with ongoing monitoring of external risks related to tariffs and consumer sentiment [94][96]

Financial Data and Key Metrics Changes - Organic sales declined by 9%, with a sequential improvement from a 4% decline in the second quarter to a 3% decline excluding Travel Retail [7][32] - Diluted earnings per share decreased by 33% to $0.65, which was better than anticipated [7][32] - Gross margin expanded by over 300 basis points, marking the fourth consecutive quarter of improvement [7][34] - Operating margin contracted by 270 basis points to 11.4%, influenced by increased consumer-facing spending [8][34] Business Line Data and Key Metrics Changes - Travel Retail experienced a significant decline of 28% organically, continuing to shrink as a percentage of the overall business [7][32] - The U.S., China, and Japan saw share gains, with Clinique, The Ordinary, and Bumble and Bumble driving gains in the U.S. [9][10] - Clinique gained share for eleven consecutive months through March, while La Mer and Estee Lauder fueled growth in China [10][11] Market Data and Key Metrics Changes - The company outperformed in key markets, gaining share in the U.S., China, and Japan, marking the first share gains in the U.S. in many years [9][10] - In China, share gains were achieved in three of the last four quarters, while Japan saw its fourth consecutive quarter of share gains [10][11] - Online organic sales grew in the fourth quarter, driven by strong performance on platforms like Amazon and TikTok [13][14] Company Strategy and Development Direction - The company is focused on its "Beauty Reimagine" strategic vision, aiming to transform its operating model to be leaner and more agile [6][32] - The five action plan priorities include accelerating consumer coverage, creating transformative innovation, boosting consumer-facing investment, fueling sustainable growth through efficiencies, and reimagining the way the company works [11][25] - The company is committed to restoring sustainable sales growth and achieving a solid double-digit adjusted operating margin over the next few years [6][32] Management's Comments on Operating Environment and Future Outlook - Management acknowledged elevated macroeconomic challenges but expressed confidence in returning to sales growth in fiscal 2026 [27][32] - The company expects continued pressure in the Travel Retail business but anticipates a moderation in organic sales decline outside of Travel Retail [27][44] - Management highlighted the importance of monitoring consumer sentiment, particularly in the U.S. and China, as it impacts inventory management and sales [27][44] Other Important Information - The company has approved initiatives to reduce over 2,600 net positions as part of its restructuring plan [25][36] - Capital expenditures were reduced by 44% compared to the previous year, reflecting a focus on optimizing capital expenditures [38] - The company is exploring additional PRGP savings and strategic pricing to mitigate potential impacts from tariffs [42][43] Q&A Session Summary Question: Inventory alignment across categories and geographies - Management noted significant progress in reducing inventory levels, particularly in Travel Retail, and emphasized ongoing monitoring of retail inventory [48][50] Question: FY 2026 planning assumptions and market trends - Management expressed confidence in returning to positive growth in FY 2026, citing market share gains in key markets and improvements in retail sales [58][60] Question: Tariff sourcing and mitigation strategies - Management indicated plans to reduce product sourced from China to below 10% by the end of the fiscal year, leveraging manufacturing capabilities in Japan and Europe [74][76] Question: PRGP savings expectations and reinvestment - Management confirmed they are on target for PRGP savings and are focused on creating efficiencies through outsourcing and procurement projects [86][90] Question: Sales growth outlook and tariff impacts - Management stated that while tariffs pose risks, they are confident in their ability to navigate these challenges and return to growth in FY 2026 [98][100]

Estee Lauder (EL) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.97 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 124.14%. A quarter ago, it was expected that this beauty products company would post earnings of $0.32 per share when it actually produced earnings of $0.62, delivering a surprise of 93.75%.Over the last four quarters, ...

Financial Performance - Net sales decreased 10% to $3.55 billion, while organic net sales decreased 9% compared to the prior year[4]. - Operating income fell 42% to $306 million, with an operating margin of 8.6%, down from 13.5% in the prior-year period[4]. - Diluted net earnings per share decreased 52% to $0.44, while adjusted diluted net earnings per share decreased 33% to $0.65[5]. - Net sales for the three months ended March 31, 2025, were $3,550 million, a decrease of 10% compared to $3,940 million in the same period of 2024[42]. - Net sales for the nine months ended March 31, 2025, were $10,915 million, a decrease of 7% compared to $11,737 million in the same period of 2024[60]. - Net earnings for the nine months ended March 31, 2025, were a loss of $587 million, compared to a profit of $695 million in 2024[67]. - Operating income (loss) for the nine months ended March 31, 2025, was $(395) million, a decline of over 100% from $1,203 million in 2024[63]. - The company's diluted net earnings per common share for the nine months ended March 31, 2025, were $(1.63), a significant decline from $1.87 in 2024[63]. Sales by Category - Skin Care net sales decreased 11%, primarily due to declines in the Asia travel retail business and lower consumer sentiment in China[11]. - Makeup net sales decreased 7%, impacted by lower shipments for new product launches and retailer destocking[15]. - Fragrance net sales decreased 1%, with strong performance from Luxury Brands like Le Labo offsetting declines in other areas[15]. - The Americas region saw a 6% decline in net sales, while Europe, the Middle East & Africa experienced an 18% decline[16]. - Net sales in North America decreased by 5%, primarily due to retail softness and elevated inventory levels, despite a low single-digit increase in retail sales[19]. Gross Margin and Operating Income - Gross margin expanded 310 basis points to 75.0%, driven by the Profit Recovery and Growth Plan, despite the decline in net sales[5]. - Operating income decreased due to net sales decline and increased consumer-facing investments, partially offset by lower cost of sales and net benefits from the PRGP[22]. - Adjusted operating income (Non-GAAP) for the nine months ended March 31, 2025, was $1,009 million, down 19% from $1,239 million in 2024[63]. - Gross profit for the nine months ended March 31, 2025, was $8,141 million, down 3% from $8,406 million in 2024, with a gross margin of 74.6%[42]. Restructuring and Future Outlook - The Profit Recovery and Growth Plan (PRGP) aims to restore a solid double-digit adjusted operating margin by fiscal 2027, with restructuring charges estimated between $1.2 billion and $1.6 billion[25][27]. - The Company expects a net sales decline of 9% to 8% for the fiscal year ending June 30, 2025, with a high-single-digit organic net sales decline in Asia/Pacific[31]. - Forecasted diluted net earnings per share (EPS) for fiscal 2025 is projected to be between -$1.89 and -$1.61, with adjusted EPS expected to decline by 50% to 40% compared to the previous year[32]. - The company plans to complete specific initiatives under the restructuring program by the end of fiscal 2026, with an expanded focus on outsourcing and evolving selling models[45]. Impairments and Charges - The company recorded an impairment charge of $773 million for the TOM FORD brand and $75 million for the Too Faced brand due to interim impairment reviews[49]. - The impairment of goodwill and other intangible assets amounted to $861 million, with no such impairment reported in 2024[67]. - The company recorded a charge of $159 million related to talcum litigation settlement agreements in the fiscal 2025 first quarter[51]. Cash Flow and Capital Expenditures - Net cash flows provided by operating activities decreased to $671 million from $1,471 million year-over-year[67]. - Capital expenditures were reduced to $395 million from $702 million in the previous year[67]. - Dividends paid decreased to $492 million from $710 million year-over-year[67]. - The company’s cash and cash equivalents decreased to $2,631 million as of March 31, 2025, from $3,701 million in 2024[65]. Macroeconomic Factors - The company continues to monitor global macroeconomic factors, including inflationary pressures and supply chain challenges, which may impact consumer purchasing behavior[33]. - The global travel retail business experienced a strong double-digit decline, influenced by subdued consumer sentiment and strategic shifts by retailers in Korea and mainland China[22].